Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs

Pasquale Stefanizzia Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy

https://orcid.org/0000-0002-3279-0196 View further author information

Andrea Martinellia Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, ItalyView further author information

Francesco Paolo Bianchia Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, ItalyView further author information

Giovanni Miglioreb Bari Policlinico General Hospital, Bari, ItalyView further author information

Silvio Tafuria Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, ItalyCorrespondence[email protected]
View further author information

"Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs." Human Vaccines & Immunotherapeutics, 18(1), pp. 1–2

Disclosure statement

No conflict of interest was reported by the authors.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs

Information for

Open access

Opportunities

Help and information

Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs

Disclosure statement

Additional information

Funding

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature